期刊文献+

p27和CyclinE的阳性表达与宫颈癌临床病理特点的关系 被引量:1

Correlation of p27 and Cyclin E expression with the clinical and pathological features of cervical carcinoma
下载PDF
导出
摘要 目的探讨p27和CyclinE在宫颈癌组织中的表达及其与肿瘤临床病理特点的关系。方法采用免疫组化SP法检测85例宫颈癌组织标本中p27及CyclinE蛋白,分析它们与肿瘤临床病理特点的关系。结果85例宫颈癌中,p27的阳性表达率为28.2%,高分化宫颈癌中p27的阳性表达率明显高于低分化者(P<0.01);有淋巴结转移的宫颈癌中p27的阳性表达率明显低于无淋巴结转移者(P<0.05)。CyclinE的阳性表达率为76.5%,低分化宫颈癌中CyclinE的阳性表达率明显高于高分化者(P<0.01)。p27与CyclinE的表达之间无明显相关关系(P>0.05)。结论p27的表达降低与宫颈癌的恶性进程和侵袭转移相关,CyclinE的高表达提示宫颈癌的恶性程度。综合分析p27和CyclinE的表达,可以评价宫颈癌的恶性程度和预后。 Objective:To investigate the expression of p27 and Cyclin E in cervical carcinoma and it's correlation with the clinical and pathological features. Methods: Expression of p27 and Cyclin E in 85 cases of cervical carcinoma were detected by immunohistocbemistry assay. In addition, relationship between expression of p27 and Cyclin E and clinic -pathologic features was studied. Results: Within 85 cases of cervical carcinoma, expression rate of p27 was 28.2%. It's expression in higher differentiated cervical carcinoma is significantly higher ( P 〈0.01 ) ; A significant higher expression in the cases without lymph node metastasis was also observed. Expression rate of Cyclin E was 76.5%. The expression of Cyclin E was significantly higher in lower differentiated cervical carcinoma ( P 〈0.01 ). There was no correlation between the expression of p27 and Cyelin E ( P 〉 0.05 ). Conclusion : Down regulation of p27 expression has close relationship with the grade of cervical carcinoma and lymph node metastasis. Up regulation of cyclin E expression correlates with its grade, p27 and Cyclin E expression can estimate the malignancy degree of cervical carcinoma and prognosis.
出处 《现代肿瘤医学》 CAS 2006年第7期871-873,共3页 Journal of Modern Oncology
关键词 P27 CYCLIN E 宫颈癌 免疫组织化学 p27 Cyclin E Cervical carcinoma Immunohistochemistry
  • 相关文献

参考文献8

  • 1张晓晖.细胞周期的网络调控系统cyclins-CDKs-CKIs及其与肿瘤的关系[J].国外医学(肿瘤学分册),1997,24(2):77-80. 被引量:28
  • 2Polyak K,Lee MH,Erdjument-Bromage H,et al.Cloning of p27Kip1,a cyclin-dependent kinase inhibitor an potential mediator of extracellular antimitogenic signals[J].Cell,1994,78:59 ~66.
  • 3Charles J.Sherr.Cancer-cell cycles[J].Science,1996,274:1672 ~ 1677.
  • 4Ponce-Castaneda MV,Lee MH,Latres E,et al.p27Kip1 chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors[J].Cancer Res,1995,55:1211 ~ 1214.
  • 5Ewen ME.Functional interactions of the retinoblastoma protein with mammalian D -type cyclins[J].Cell,1993,73:487 ~497.
  • 6Buckley MF,Sweeney KJE,Hamilton JA,et al.Expression an d amplification of cyclin genes in human breast cancer[J].Oncogene,1993,8:2127 ~ 2133.
  • 7Porter PL,Malone KE,Heagerty PJ,et al.Expression of cell-cycle regulators p27Kipl and cyclin E,alone and in combination,correlate with survival in young breast cancer patients[J].Nature Medicion,1997,3:222 ~ 225.
  • 8Tshihlias J,Kapusta LR,Deboer G,et al.Loss of cyclin-dependent kinase inhibitor p27Kipl is a novel prognostic factor in localized human prostate adenocarcinoma[J].Cancer Res,1998,58:542~ 548.

共引文献27

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部